About Axela Biosensors
Axela is delivering on its mission to provide a simple and effective approach to personalized medicine by exploiting the dotLab System in research markets today to generate tomorrow's diagnostics. This strategy of offering a common technology platform to both markets aims to provide a opportunity to capitalize on discoveries. The approach has already resulted in applications with the potential to address segments of the large, underserved markets of oncology and cardiology that will be the focus of two funded clinical trials this summer and growing installed customer base. For a time these leading clinical researchers can use the direct understanding of protein interactions to develop quantitative assays on a single platform. dot technology has shortened the transition from protein discovery to application. The ability to measure biomolecular complexes in real-time aims to provide for new approaches to disease management.
Axela Biosensors Patents
Axela Biosensors has filed 12 patents.
Fluid dynamics, Analytical chemistry, Fluid mechanics, Mass spectrometry, Valves
Fluid dynamics, Analytical chemistry, Fluid mechanics, Mass spectrometry, Valves
Latest Axela Biosensors News
Aug 22, 2018
Summary Axela Inc Axela, formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flowthru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and applications support, onsite and inhouse training, extended warranty, service and maintenance contracts; and custom application development services. The company creates tools and content to simplify multiplex biomarker detection for translational research and diagnostic testing. It markets its products through a network of distributors in Canada, Ireland, Belgium, Luxemburg, Spain, the Netherlands, the UK and the US. Axela is headquartered in Toronto, Ontario, Canada. Axela Inc Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News
Axela Biosensors Frequently Asked Questions (FAQ)
Where is Axela Biosensors's headquarters?
Axela Biosensors's headquarters is located at 50 Ronson Drive, Toronto.
What is Axela Biosensors's latest funding round?
Axela Biosensors's latest funding round is Unattributed VC - II.
How much did Axela Biosensors raise?
Axela Biosensors raised a total of $5.8M.
Who are the investors of Axela Biosensors?
Investors of Axela Biosensors include VG Partners, MMV Financial, Threshold Ventures and Covington Funds.
Who are Axela Biosensors's competitors?
Competitors of Axela Biosensors include Sesen Bio, MolecularMD, Amnis Corporation, Inotek Pharmaceuticals, Pieris and 7 more.
Compare Axela Biosensors to Competitors
VARi has several research programs in basic sciences that will improve our understanding of the cancer process, including programs rich in functional genomics. They have a long-term commitment to the development of programs that facilitate the translation of these basic science discoveries into therapeutic strategies for attacking cancer and thus improving human health.
Solidus Biosciences is a company focused on providing business intelligence in the pharmaceutical and biologic drugs sector. The company's main services include offering insights on life cycle management, brand erosion, generic entry, biosimilars, patents, sales, litigation, and more, all related to pharmaceutical and biologic drugs. The company primarily serves the biopharmaceutical industry. It is based in Troy, New York.
Evogen is a company that focuses on neurology proteomics and genomics in the biotechnology and healthcare sectors. The company offers technologies that provide rapid, accurate, and convenient solutions in neurology precision medicine, reagent technology, and biothreat analysis. These technologies are used to detect and diagnose neurological diseases, detect threatening chemicals and biological pathogens, and allow healthcare providers to detect pathogens for infectious diseases. It was founded in 2001 and is based in Lenexa, Kansas.
Chalex Corporation's precision-made chambered McMaster counting slides are used by researchers, laboratories, nematologists and veterinary practitioners throughout the world. Made of clear durable acrylic for long-lasting use, the company's slides also feature exact volumes thanks to injection-molded accuracy which yield consistent test results compared to other slides with handmade chamber spacers. The quality of these slides make them the standard the world over.
Everist Health (formerly Everist Genomics and Genetics Squared) is a personalized medicine company which develops and commercializes medically unique diagnostics, prognostics and therapeutic selection technologies. Through their tools, the company seeks to help physicians improve medical outcomes and reduce the total cost of care. EGI's products integrate with mobile digital services, smartphones, and tablet computers resulting in advanced medical technology.
PrimaDiag is a start-up developing tools to automate biological processes for diagnostics and research